These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 8132404)

  • 1. Perfluorooctylbromide (PFOB) as a vitreous substitute in non-human primates.
    Conway MD; Peyman GA; Karaçorlu M; Bhatt N; Soike KF; Clark LC; Hoffmann RE
    Int Ophthalmol; 1993 Oct; 17(5):259-64. PubMed ID: 8132404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term vitreous replacement in primates with intravitreal Vitreon or Vitreon plus silicone.
    Peyman GA; Conway MD; Soike KF; Clark LC
    Ophthalmic Surg; 1991 Nov; 22(11):657-64. PubMed ID: 1792032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of chemical stability and purification of perfluorocarbon liquids in experimental extended-term vitreous substitution.
    Velikay M; Stolba U; Wedrich A; Li Y; Datlinger P; Binder S
    Graefes Arch Clin Exp Ophthalmol; 1995 Jan; 233(1):26-30. PubMed ID: 7721120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Perfluorohexyloctane as a long-term vitreous tamponade in the experimental animal. Experimental perfluorohexyloctane substitution.
    Zeana D; Becker J; Kuckelkorn R; Kirchhof B
    Int Ophthalmol; 1999; 23(1):17-24. PubMed ID: 11008894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraocular tolerance of perfluorooctylbromide (perflubron).
    Flores-Aguilar M; Munguia D; Loeb E; Crapotta JA; Vuong C; Shakiba S; Bergeron-Lynn G; Wiley CA; Weers J; Freeman WR
    Retina; 1995; 15(1):3-13. PubMed ID: 7754245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental evaluation of perfluorophenanthrene as a high specific gravity vitreous substitute: a preliminary report.
    Nabih M; Peyman GA; Clark LC; Hoffman RE; Miceli M; Abou-Steit M; Tawakol M; Liu KR
    Ophthalmic Surg; 1989 Apr; 20(4):286-93. PubMed ID: 2733997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polylactic acid for visualizing the vitreous body during vitrectomy.
    Yamashita T; Sakamoto T; Yamakiri K; Miura M; Enaida H; Ueno A; Atsumi I; Matsuhisa K; Sakamoto Y; Kida T; Ishibashi T
    Invest Ophthalmol Vis Sci; 2007 Jul; 48(7):3277-82. PubMed ID: 17591899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of silicone gel as a long-term vitreous substitute in non-human primates.
    Peyman GA; Conway MD; Karaçorlu M; Soike KF; Bhatt N; Clark LC; Hoffmann RE
    Ophthalmic Surg; 1992 Dec; 23(12):811-7. PubMed ID: 1494435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental long-term vitreous replacement with purified and nonpurified perfluorodecalin.
    Velikay M; Wedrich A; Stolba U; Datlinger P; Li Y; Binder S
    Am J Ophthalmol; 1993 Nov; 116(5):565-70. PubMed ID: 8238215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorohexylethan (O62) as ocular endotamponade in complex vitreoretinal surgery.
    Hoerauf H; Roider J; Kobuch K; Laqua H
    Retina; 2005 Jun; 25(4):479-88. PubMed ID: 15933596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental vitreous and aqueous replacement with perfluorophenanthrene. Clinical, histologic, and electrophysiologic results.
    Stolba U; Krepler K; Pflug R; Velikay M; Wedrich A; Binder S
    Retina; 1997; 17(2):146-53. PubMed ID: 9143044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorinated organic liquid as an intraocular oxygen reservoir for the ischemic retina.
    Wilson CA; Berkowitz BA; Srebro R
    Invest Ophthalmol Vis Sci; 1995 Jan; 36(1):131-41. PubMed ID: 7822140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental vitreous replacement with perfluorotributylamine.
    Chang S; Zimmerman NJ; Iwamoto T; Ortiz R; Faris D
    Am J Ophthalmol; 1987 Jan; 103(1):29-37. PubMed ID: 3799787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluorocarbon perfused vitrectomy: animal studies.
    Quiroz-Mercado H; Suarez-Tatá L; Magdalenic R; Murillo-López S; García-Aguirre G; Guerrero-Naranjo J; Rodríguez-Reyes AA
    Am J Ophthalmol; 2004 Feb; 137(2):287-93. PubMed ID: 14962419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using spectral-domain optical coherence tomography imaging to identify the presence of retinal silicone oil emulsification after silicone oil tamponade.
    Errera MH; Liyanage SE; Elgohary M; Day AC; Wickham L; Patel PJ; Sahel JA; Paques M; Ezra E; Sullivan PM
    Retina; 2013 Sep; 33(8):1567-73. PubMed ID: 23591533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental vitreous replacement with perfluorophenanthrene.
    Ratiglia R; Berti E; Galimberti D; Bindella A; Schweizer F; Marchi L; Rossi A
    Eur J Ophthalmol; 1997; 7(1):59-63. PubMed ID: 9101197
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Histopathologic studies of the rabbit retina after use of perfluorodecalin].
    Mackiewicz J; Szczesny P; Zagórski Z
    Klin Oczna; 1998; 100(1):5-8. PubMed ID: 9685790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A cross-linked hyaluronic acid hydrogel (Healaflow(®)) as a novel vitreous substitute.
    Barth H; Crafoord S; Andréasson S; Ghosh F
    Graefes Arch Clin Exp Ophthalmol; 2016 Apr; 254(4):697-703. PubMed ID: 26743755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biocompatibility of silicone, fluorosilicone and perfluorocarbon liquids as vitreous tamponades. an ultrastructural and immunohistochemical study.
    Versura P; Cellini M; Torreggiani A; Bernabini B; Rossi A; Moretti M; Caramazza R
    Ophthalmologica; 2001; 215(4):276-83. PubMed ID: 11399935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental retinal tolerance to very low viscosity silicone oil (100 cs) as a vitreous substitute compared to higher viscosity silicone oil (5000 cs).
    Soheilian M; Peyman GA; Moritera T; Wafapoor H
    Int Ophthalmol; 1995; 19(1):57-61. PubMed ID: 8537198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.